Matt BakerSenior Director, Strategy and Business Development at Thermo Fisher Scientific
Matt joined Thermo Fisher Scientific in 2008 and currently leads business development and strategy for their Protein and Cell Analysis business. Over his more than 25-year career, he has focused extensively on developing and characterizing antibodies. Most recently, Matt helped support and organize an international initiative with Mathias Uhlen and other leading researchers to better validate antibodies through establishing standards on antibody specificity and applications testing. He continues to play key roles in supporting organizations and promoting standards that help scientists be more successful in their research through better validation and testing.